Lusis AJ: Atherosclerosis. Nature. 2000, 407: 233-241. 10.1038/35025203.
Article
PubMed Central
CAS
PubMed
Google Scholar
Libby P, Ridker PM, Maseri A: Inflammation and atherosclerosis. Circulation. 2002, 105: 1135-1143. 10.1161/hc0902.104353.
Article
CAS
PubMed
Google Scholar
Bobryshev YV: Monocyte recruitment and foam cell formation in atherosclerosis. Micron. 2006, 37: 208-222. 10.1016/j.micron.2005.10.007.
Article
CAS
PubMed
Google Scholar
Moore KJ, Tabas I: Macrophages in the pathogenesis of atheroscleros. Cell. 2011, 145: 345-355. 10.1016/j.cell.2011.04.005.
Article
Google Scholar
Galis ZS, Sukhova GK, Kranzhofer R, Clark S, Libby P: Macrophage foam cells from experimental atheroma constitutively produce matrix-degrading proteinases. Proc Natl Acad Sci U S A. 1995, 92: 402-406. 10.1073/pnas.92.2.402.
Article
PubMed Central
CAS
PubMed
Google Scholar
Zhou J, Zhu P, Jiang JL, Zhang Q, Wu ZB, Yao XY, Tang H, Lu N, Yang Y, Chen ZN: Involvement of CD147 in overexpression of MMP-2 and MMP-9 and enhancement of invasive potential of PMA-differentiated THP-1. BMC Cell Biol. 2005, 6: 25-10.1186/1471-2121-6-25.
Article
PubMed Central
PubMed
Google Scholar
Gough PJ, Gomez IG, Wille PT, Raines EW: Macrophage expression of active MMP-9 induces acute plaque disruption in apoE-deficient mice. J Clin Invest. 2006, 116: 59-69. 10.1172/JCI25074.
Article
PubMed Central
CAS
PubMed
Google Scholar
Schmidt R, Redecke V, Breitfeld Y, Wantia N, Miethke T, Massberg S, Fischel S, Neumann FJ, Schomig A, May AE: EMMPRIN (CD 147) is a central activator of extracellular matrix degradation by Chlamydia pneumoniae-infected monocytes. Implications for plaque rupture. Thromb Haemost. 2006, 95: 151-158.
CAS
PubMed
Google Scholar
Schaar JA, Muller JE, Falk E, Virmani R, Fuster V, Serruys PW, Colombo A, Stefanadis C, Ward Casscells S, Moreno PR, Maseri A, van der Steen AF: Terminology for high-risk and vulnerable coronary artery plaques. Report of a meeting on the vulnerable plaque, June 17 and 18 2003, Santorini, Greece. Eur Heart J. 2004, 25: 1077-1082. 10.1016/j.ehj.2004.01.002.
Article
PubMed
Google Scholar
Carr S, Farb A, Pearce WH, Virmani R, Yao JS: Atherosclerotic plaque rupture in symptomatic carotid artery stenosis. J Vasc Surg. 1996, 23: 755-765. 10.1016/S0741-5214(96)70237-9. discussion 765–756
Article
CAS
PubMed
Google Scholar
Ikram M: A review on the chemical and pharmacological aspects of genus Berberis. Planta Med. 1975, 28: 353-358. 10.1055/s-0028-1097869.
Article
CAS
PubMed
Google Scholar
Huang Z, Meng S, Wang L, Wang Y, Chen T, Wang C: Suppression of oxLDL-induced MMP-9 and EMMPRIN expression by berberine via inhibition of NF-kappaB activation in human THP-1 macrophages. Anat Rec (Hoboken). 2012, 295: 78-86. 10.1002/ar.21489.
Article
CAS
Google Scholar
Huang Z, Wang L, Meng S, Wang Y, Chen T, Wang C: Berberine reduces both MMP-9 and EMMPRIN expression through prevention of p38 pathway activation in PMA-induced macrophages. Int J Cardiol. 2011, 146: 153-158. 10.1016/j.ijcard.2009.06.023.
Article
PubMed
Google Scholar
Meng S, Wang LS, Huang ZQ, Zhou Q, Sun YG, Cao JT, Li YG, Wang CQ: Berberine ameliorates inflammation in patients with acute coronary syndrome following percutaneous coronary intervention. Clin Exp Pharmacol Physiol. 2012, 39: 406-411. 10.1111/j.1440-1681.2012.05670.x.
Article
CAS
PubMed
Google Scholar
Turner N, Li JY, Gosby A, To SW, Cheng Z, Miyoshi H, Taketo MM, Cooney GJ, Kraegen EW, James DE, Hu LH, Li J, Ye JM: Berberine and its more biologically available derivative, dihydroberberine, inhibit mitochondrial respiratory complex I: a mechanism for the action of berberine to activate AMP-activated protein kinase and improve insulin action. Diabetes. 2008, 57: 1414-1418. 10.2337/db07-1552.
Article
CAS
PubMed
Google Scholar
Cheng Z, Chen AF, Wu F, Sheng L, Zhang HK, Gu M, Li YY, Zhang LN, Hu LH, Li JY, Li J: 8,8-Dimethyldihydroberberine with improved bioavailability and oral efficacy on obese and diabetic mouse models. Bioorg Med Chem. 2010, 18: 5915-5924. 10.1016/j.bmc.2010.06.085.
Article
CAS
PubMed
Google Scholar
Tsuchiya S, Kobayashi Y, Goto Y, Okumura H, Nakae S, Konno T, Tada K: Induction of maturation in cultured human monocytic leukemia cells by a phorbol diester. Cancer Res. 1982, 42: 1530-1536.
CAS
PubMed
Google Scholar
Beattie JH, Duthie SJ, Kwun IS, Ha TY, Gordon MJ: Rapid quantification of aortic lesions in apoE(−/−) mice. J Vasc Res. 2009, 46: 347-352. 10.1159/000189795.
Article
CAS
PubMed
Google Scholar
Kuzuya M, Nakamura K, Sasaki T, Cheng XW, Itohara S, Iguchi A: Effect of MMP-2 deficiency on atherosclerotic lesion formation in apoE-deficient mice. Arterioscler Thromb Vasc Biol. 2006, 26: 1120-1125. 10.1161/01.ATV.0000218496.60097.e0.
Article
CAS
PubMed
Google Scholar
Tangirala RK, Rubin EM, Palinski W: Quantitation of atherosclerosis in murine models: correlation between lesions in the aortic origin and in the entire aorta, and differences in the extent of lesions between sexes in LDL receptor-deficient and apolipoprotein E-deficient mice. J Lipid Res. 1995, 36: 2320-2328.
CAS
PubMed
Google Scholar
Dansky HM, Charlton SA, Harper MM, Smith JD: T and B lymphocytes play a minor role in atherosclerotic plaque formation in the apolipoprotein E-deficient mouse. Proc Natl Acad Sci U S A. 1997, 94: 4642-4646. 10.1073/pnas.94.9.4642.
Article
PubMed Central
CAS
PubMed
Google Scholar
Yang JM, Xu Z, Wu H, Zhu H, Wu X, Hait WN: Overexpression of extracellular matrix metalloproteinase inducer in multidrug resistant cancer cells. Mol Cancer Res. 2003, 1: 420-427.
CAS
PubMed
Google Scholar
Li R, Huang L, Guo H, Toole BP: Basigin (murine EMMPRIN) stimulates matrix metalloproteinase production by fibroblasts. J Cell Physiol. 2001, 186: 371-379. 10.1002/1097-4652(2000)9999:999<000::AID-JCP1042>3.0.CO;2-8.
Article
CAS
PubMed
Google Scholar
Min KJ, Um HJ, Cho KH, Kwon TK: Curcumin inhibits oxLDL-induced CD36 expression and foam cell formation through the inhibition of p38 MAPK phosphorylation. Food Chem Toxicol. 2013, 58: 77-85. 10.1016/j.fct.2013.04.008.
Article
CAS
PubMed
Google Scholar
Iiyama K, Hajra L, Iiyama M, Li H, DiChiara M, Medoff BD, Cybulsky MI: Patterns of vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 expression in rabbit and mouse atherosclerotic lesions and at sites predisposed to lesion formation. Circ Res. 1999, 85: 199-207. 10.1161/01.RES.85.2.199.
Article
CAS
PubMed
Google Scholar
Libby P: Current concepts of the pathogenesis of the acute coronary syndromes. Circulation. 2001, 104: 365-372. 10.1161/01.CIR.104.3.365.
Article
CAS
PubMed
Google Scholar
Fiotti N, Altamura N, Orlando C, Simi L, Reimers B, Pascotto P, Zingone B, Pascotto A, Serio M, Guarnieri G, Giansante C: Metalloproteinases-2, –9 and TIMP-1 expression in stable and unstable coronary plaques undergoing PCI. Int J Cardiol. 2008, 127: 350-357. 10.1016/j.ijcard.2007.05.011.
Article
PubMed
Google Scholar
Blankenberg S, Rupprecht HJ, Poirier O, Bickel C, Smieja M, Hafner G, Meyer J, Cambien F, Tiret L: Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease. Circulation. 2003, 107: 1579-1585. 10.1161/01.CIR.0000058700.41738.12.
Article
CAS
PubMed
Google Scholar
Major TC, Liang L, Lu X, Rosebury W, Bocan TM: Extracellular matrix metalloproteinase inducer (EMMPRIN) is induced upon monocyte differentiation and is expressed in human atheroma. Arterioscler Thromb Vasc Biol. 2002, 22: 1200-1207. 10.1161/01.ATV.0000021411.53577.1C.
Article
CAS
PubMed
Google Scholar
Monaco C, Paleolog E: Nuclear factor kappaB: a potential therapeutic target in atherosclerosis and thrombosis. Cardiovasc Res. 2004, 61: 671-682. 10.1016/j.cardiores.2003.11.038.
Article
CAS
PubMed
Google Scholar
Yamamoto Y, Gaynor RB: IkappaB kinases: key regulators of the NF-kappaB pathway. Trends Biochem Sci. 2004, 29: 72-79. 10.1016/j.tibs.2003.12.003.
Article
CAS
PubMed
Google Scholar
Olson CM, Hedrick MN, Izadi H, Bates TC, Olivera ER, Anguita J: p38 mitogen-activated protein kinase controls NF-kappaB transcriptional activation and tumor necrosis factor alpha production through RelA phosphorylation mediated by mitogen- and stress-activated protein kinase 1 in response to Borrelia burgdorferi antigens. Infect Immun. 2007, 75: 270-277. 10.1128/IAI.01412-06.
Article
PubMed Central
CAS
PubMed
Google Scholar
Muslin AJ: MAPK signalling in cardiovascular health and disease: molecular mechanisms and therapeutic targets. Clin Sci (Lond). 2008, 115: 203-218. 10.1042/CS20070430.
Article
CAS
Google Scholar
Rahaman SO, Lennon DJ, Febbraio M, Podrez EA, Hazen SL, Silverstein RL: A CD36-dependent signaling cascade is necessary for macrophage foam cell formation. Cell Metab. 2006, 4: 211-221. 10.1016/j.cmet.2006.06.007.
Article
PubMed Central
CAS
PubMed
Google Scholar
Zhao M, Liu Y, Wang X, New L, Han J, Brunk UT: Activation of the p38 MAP kinase pathway is required for foam cell formation from macrophages exposed to oxidized LDL. APMIS. 2002, 110: 458-468. 10.1034/j.1600-0463.2002.100604.x.
Article
CAS
PubMed
Google Scholar
Choi HJ, Chung TW, Kim JE, Jeong HS, Joo M, Cha J, Kim CH, Ha KT: Aesculin inhibits matrix metalloproteinase-9 expression via p38 mitogen activated protein kinase and activator protein 1 in lipopolysachride-induced RAW264.7 cells. Int Immunopharmacol. 2012, 14: 267-274. 10.1016/j.intimp.2012.07.013.
Article
CAS
PubMed
Google Scholar
Kim YM, Kim MY, Kim HJ, Roh GS, Ko GH, Seo HG, Lee JH, Chang KC: Compound C independent of AMPK inhibits ICAM-1 and VCAM-1 expression in inflammatory stimulants-activated endothelial cells in vitro and in vivo. Atherosclerosis. 2011, 219: 57-64. 10.1016/j.atherosclerosis.2011.06.043.
Article
CAS
PubMed
Google Scholar
Lee YS, Lan Tran HT, Van Ta Q: Regulation of expression of matrix metalloproteinase-9 by JNK in Raw 264.7 cells: presence of inhibitory factor(s) suppressing MMP-9 induction in serum and conditioned media. Exp Mol Med. 2009, 41: 259-268. 10.3858/emm.2009.41.4.029.
Article
PubMed Central
CAS
PubMed
Google Scholar